egov.mn

Targeting an atypical G protein–coupled receptor signaling pathway for cardiac fibrosis therapy | Science

This story was prepared automatically by software.

Targeting an atypical G protein–coupled receptor signaling pathway for cardiac fibrosis therapy | Science

Cardiac fibrosis independently predicts adverse outcomes in heart failure (HF), yet no Food and Drug Administration–approved therapy directly targets fibrotic remodeling in the heart. To address this unmet clinical need, we used a multidimensional drug ...

Share
Next storyLittle-known arm of immune system could be key to better vaccines, cancer therapies
Newsletter

Get the latest news delivered to your inbox.

Related articles